Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.
N Engl J Med
; 387(3): 217-226, 2022 07 21.
Article
in En
| MEDLINE
| ID: mdl-35857659
Full text:
1
Database:
MEDLINE
Main subject:
Antibodies, Monoclonal, Humanized
/
Triple Negative Breast Neoplasms
/
Immune Checkpoint Inhibitors
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
N Engl J Med
Year:
2022
Type:
Article